Institutional Ownership
Drugs Made In Amer Acq II Co
CUSIP G2851K104USD ORD SHSQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
10.2%
Max % of class reported
Institutional Holders
68
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Oct 2, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 2, 2025 | Drugs Made In America Acquisition II LLC | 13D | 10.2% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Magnetar Financial LLC | 2.70M | $26.95M |
| 2 | Mmcap International Inc. Spc | 2.70M | $26.92M |
| 3 | Karpus Management, Inc. | 2.60M | $25.90M |
| 4 | Healthcare Of Ontario Pension Plan Trust Fund | 2.00M | $19.96M |
| 5 | Millennium Management LLC | 1.98M | $19.70M |
| 6 | Hudson Bay Capital Management LP | 1.97M | $19.65M |
| 7 | Wolverine Asset Management LLC | 1.80M | $17.90M |
| 8 | Polar Asset Management Partners Inc. | 1.50M | $14.96M |
| 9 | Tenor Capital Management Co., L.P. | 1.50M | $14.96M |
| 10 | D. E. Shaw & Co., Inc. | 1.39M | $13.87M |